Free Trial
NASDAQ:NCNA

NuCana (NCNA) Stock Price, News & Analysis

NuCana logo
$3.40 -0.05 (-1.31%)
As of 03:44 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About NuCana Stock (NASDAQ:NCNA)

Key Stats

Today's Range
$3.40
$3.60
50-Day Range
$3.11
$26.24
52-Week Range
$3.05
$1,650.00
Volume
251,554 shs
Average Volume
537,882 shs
Market Capitalization
$101.85 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5,000.00
Consensus Rating
Moderate Buy

Company Overview

NuCana Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
68th Percentile Overall Score

NCNA MarketRank™: 

NuCana scored higher than 68% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    NuCana has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    NuCana has received no research coverage in the past 90 days.

  • Read more about NuCana's stock forecast and price target.
  • Earnings Growth

    Earnings for NuCana are expected to grow in the coming year, from ($13.42) to ($10.52) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of NuCana is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of NuCana is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    NuCana has a P/B Ratio of 0.01. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    290.48% of the float of NuCana has been sold short.
  • Short Interest Ratio / Days to Cover

    NuCana has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in NuCana has recently decreased by 99.79%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    NuCana does not currently pay a dividend.

  • Dividend Growth

    NuCana does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    290.48% of the float of NuCana has been sold short.
  • Short Interest Ratio / Days to Cover

    NuCana has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in NuCana has recently decreased by 99.79%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    NuCana has a news sentiment score of 0.75. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for NuCana this week, compared to 1 article on an average week.
  • Search Interest

    Only 25 people have searched for NCNA on MarketBeat in the last 30 days. This is a decrease of -57% compared to the previous 30 days.
  • MarketBeat Follows

    36 people have added NuCana to their MarketBeat watchlist in the last 30 days. This is an increase of 112% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, NuCana insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    31.20% of the stock of NuCana is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    44.00% of the stock of NuCana is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about NuCana's insider trading history.
Receive NCNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NuCana and its competitors with MarketBeat's FREE daily newsletter.

NCNA Stock News Headlines

Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.tc pixel
Wall Street Zen Upgrades NuCana (NASDAQ:NCNA) to "Sell"
NuCana Announces ADS Ratio Change
See More Headlines

NCNA Stock Analysis - Frequently Asked Questions

NuCana's stock was trading at $238.00 at the start of the year. Since then, NCNA shares have decreased by 98.5% and is now trading at $3.49.

NuCana PLC Sponsored ADR (NASDAQ:NCNA) posted its quarterly earnings data on Wednesday, August, 20th. The company reported ($0.16) earnings per share for the quarter, topping analysts' consensus estimates of ($2.75) by $2.59.

NuCana shares reverse split on the morning of Friday, August 8th 2025.The 1-200 reverse split was announced on Friday, July 11th 2025. The number of shares owned by shareholders was adjusted after the market closes on Thursday, August 7th 2025. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

NuCana (NCNA) raised $100 million in an IPO on Thursday, September 28th 2017. The company issued 6,700,000 shares at a price of $14.00-$16.00 per share. Citigroup, Jefferies and Cowen acted as the underwriters for the IPO and William Blair was co-manager.

Shares of NCNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that NuCana investors own include VBI Vaccines (VBIV), Anavex Life Sciences (AVXL), Sorrento Therapeutics (SRNE), Plug Power (PLUG), SCYNEXIS (SCYX), Allena Pharmaceuticals (ALNA) and CRISPR Therapeutics (CRSP).

Company Calendar

Last Earnings
8/20/2025
Today
8/25/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:NCNA
CIK
1709626
Fax
N/A
Employees
30
Year Founded
N/A

Price Target and Rating

High Price Target
$5,000.00
Low Price Target
$5,000.00
Potential Upside/Downside
+145,248.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($646.16)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$24.28 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-592.28%
Return on Assets
-208.68%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.58
Quick Ratio
1.58

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$267.86 per share
Price / Book
0.01

Miscellaneous

Outstanding Shares
30,000
Free Float
21,000
Market Cap
$103.20 thousand
Optionable
Not Optionable
Beta
1.40

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:NCNA) was last updated on 8/25/2025 by MarketBeat.com Staff
From Our Partners